Silicon Valley-based The One Health Company which is working on helping canine cancer treatment more accessible and affordable has secured a $5 million fresh seed round investment. The investment round was led by Andreessen Horowitz with participation from existing investor Y Combinator and Lerer Hippeau.
The latest financing takes the total amount raised by the company to $6.4 million in funding. The company's flagship product FidoCure helps the users buy treatment plans for a fixed rate and have access to canine cancer care. The product provides solutions and recommendations to the human, helping them understand the best therapeutic implications and targeted treatment.
Started in 2016 by Benjamin Lewis, Christina Kelly Lopes, Franca Angeli Brownstein, Jonathan Lustgarten, and Ravi Tolwani, the company uses gene sequencing to figure out the exact genetic mutation which causes cancer in the dog.
Christina Lopes, the CEO of One Health commenting about the company said, "At One Health, we're committed to advancing veterinary medicine and helping our beloved dogs live longer, healthier and happier lives. By using the same diagnostics, machine learning rules, and drugs that are currently on the market for people, we're able to provide pet parents with cutting-edge cancer treatments at an affordable cost."
Andreessen Horowitz's general partner Jorge Conde talking about their investment in the company said, "Advances in our understanding of cancer biology have revolutionized how we diagnose and treat human cancers. As research continues to uncover similarities between certain dog and human cancers, One Health not only will harness these advances to transform how we care for our pets, but also has a unique opportunity to impact human health as it discovers better ways to manage this devastating disease in dogs."
Image Courtesy : the one health